Consensus Inari Medical, Inc.

Equities

NARI

US45332Y1091

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
38.07 ^USD	-0.29%		-1.48%	-41.36%

Apr. 02	Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	CI
Apr. 01	Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	CI

Evolution of the average Target Price on Inari Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4d32d9.ZfS6QMzHVXRHhmZgFDqXsjqb2JvqQg95rpRog9ijkfM.FZXZJqOTeCMB0FM3XnXi_E6ildySGG4cnvIxzZ_8qLQOp5conK4fBCHTMw~517f955464627af120dabb2c178c8ad2

Analyst Recommendations on Inari Medical, Inc.

Truist Securities Cuts Inari Medical's Price Target to $52 From $61, Reiterates Hold Rating	Mar. 22	MT
Piper Sandler Downgrades Inari Medical to Neutral From Overweight, Cuts Price Target to $55 From $85	Feb. 29	MT
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating	Feb. 29	MT
Needham Initiates Inari Medical With Buy Rating, $72 PT; Notes 'Attractive' Valuation, Expects 'Rapid' Improvement in Margin, Earnings in 2025, Beyond	Jan. 23	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $65, Maintains Hold Rating	Dec. 22	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $70, Keeps Hold Rating	23-07-19	MT
Baird Initiates Inari Medical With Outperform Rating, $79 Price Target	23-07-19	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $68, Keeps Hold Rating	23-04-18	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $80 From $77, Maintains Buy Rating	23-02-28	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $77 From $76, Maintains Buy Rating	23-02-21	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $75, Maintains Hold Rating	23-01-31	MT
Jefferies Adjusts Inari Medical's Price Target to $91 From $89, Maintains Buy Rating	23-01-12	MT
Morgan Stanley Cuts Price Target on Inari Medical to $83 From $95, Affirms Overweight Rating	23-01-06	MT
Truist Securities Adjusts Price Target on Inari Medical to $75 From $84, Maintains Hold Rating	22-12-20	MT
Morgan Stanley Adjusts Price Target on Inari Medical to $95 From $93, Maintains Overweight Rating	22-11-03	MT
Berenberg Bank Adjusts Inari Medical Price Target to $86 From $85, Maintains Buy Rating	22-11-03	MT
BTIG Trims Inari Medical's Price Target to $97 From $100, Maintains Buy Rating	22-10-17	MT
Truist Securities Adjusts Price Target on Inari Medical to $80 From $87, Maintains Hold Rating	22-10-17	MT
Jefferies Starts Inari Medical at Buy With $88 Price Target	22-10-12	MT
Berenberg Bank Initiates Coverage on Inari Medical With Buy Rating, $85 Price Target	22-09-29	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $94 From $92, Reiterates Buy Rating	22-09-16	MT
Truist Securities Initiates Inari Medical at Hold With $87 Price Target	22-09-13	MT
Morgan Stanley Lowers Inari Medical's Price Target to $93 From $108, Maintains Overweight Rating	22-07-15	MT
BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating	22-06-24	MT
Inari Medical's Shares Rise After Piper Sandler Initiates Coverage	22-06-21	MT